4894.T
Cuorips Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 5,780.00
+2.66%Sep 15, 2026, 11:34 UTC
AstraZeneca's Japan subsidiary invited three Japanese drug-discovery and medical-device startups, including Cuorips, to its global headquarters in Cambridge, UK, for discussions on overseas expansion as part of an Osaka Prefecture-backed startup support program.
Source:Sep 12, 2026, 00:30 UTC
Qualips conducted a third-party allotment of 619,700 new shares at 4,841 yen per share to JICVGI Opportunity Fund No. 1 Investment Limited Partnership.
Source:Jul 29, 2026, 06:47 UTC
The Central Social Insurance Medical Council (Chuikyo) approved the insurance reimbursement price for Qualips' iPS cell-derived myocardial cell sheet 'Reheart'.
Source: